Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0; the page now reflects the newer revision label.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision label has been updated from v3.4.1 to v3.4.2, a minor update with no changes to the study data or display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 as the site version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedMinor UI and wording updates were made, including glossary show/hide options, capitalization tweaks in QC criteria labels, and revision/version strings (v3.4.0 added, v3.3.4 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.